Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35.220
Filtrar
2.
Brain Nerve ; 76(8): 923-931, 2024 Aug.
Artículo en Japonés | MEDLINE | ID: mdl-39117593

RESUMEN

Headache is the most common condition encountered in neurological practice. However, despite the burden to patients, migraine, a typical primary headache, is not life-threatening, and evaluation shows no abnormalities; therefore, it is often treated using analgesics. Moreover, patients often do not visit hospitals and clinics because over-the-counter analgesics, such as nonsteroidal anti-inflammatory drugs are easily available. However, many patients continue to experience headaches. Migraine therapy has progressed remarkably following the advent of calcitonin gene-related peptide antibody drugs in recent years. Many patients with migraine do not visit hospitals and clinics and do not receive appropriate treatment. Therefore, in the future, neurologists will need to play a key role in patient education and in training physicians to enable accurate diagnosis of headaches.


Asunto(s)
Cefalea , Humanos , Cefalea/terapia , Cefalea/diagnóstico , Cefalea/tratamiento farmacológico , Trastornos Migrañosos/diagnóstico , Trastornos Migrañosos/tratamiento farmacológico , Trastornos Migrañosos/terapia , Péptido Relacionado con Gen de Calcitonina/antagonistas & inhibidores
3.
Acute Med ; 23(2): 75-80, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39132730

RESUMEN

Headache accounts for 1 - 3% of emergency department (ED) visits globally and is associated with elevated blood pressure (BP). It is unclear if anti-hypertensive therapy provides benefits. This retrospective study assessed effects of anti-hypertensive therapy in ED headache patients on rescue analgesic need, hospital admissions, and length of stay (LOS). 1385 patients were included. 366 received anti-hypertensive therapy. The anti-hypertensive therapy cohort was older (p < 0.001) with increased odds of admission (p < 0.001) and 2.385 hrs longer ED LOS (p < 0.001). No difference in rescue analgesia was found (p < 0.429). Anti-hypertensive therapy in hypertensive ED headache patients is associated with increased hospital admission and ED LOS, but no difference in rescue analgesia utilization.


Asunto(s)
Antihipertensivos , Servicio de Urgencia en Hospital , Cefalea , Hipertensión , Tiempo de Internación , Humanos , Femenino , Masculino , Estudios Retrospectivos , Persona de Mediana Edad , Hipertensión/tratamiento farmacológico , Cefalea/tratamiento farmacológico , Cefalea/etiología , Antihipertensivos/uso terapéutico , Tiempo de Internación/estadística & datos numéricos , Adulto , Anciano
4.
Neurology ; 103(5): e209759, 2024 Sep 10.
Artículo en Inglés | MEDLINE | ID: mdl-39137382

RESUMEN

A 7-year-old right-handed girl presented to the pediatric neurology outpatient clinic after 5 episodes of headache over the previous 3 months. Her family history was positive for migraine in the mother and maternal grandmother and for febrile seizures in the older sister. The neurologic examination and cognitive profile were normal. Five seconds after the end of hyperventilation, video-EEG showed high-amplitude delta waves predominantly over the left hemisphere with concomitant acute aphasia and right-sided weakness. After the event, which self-resolved over 8 minutes, the girl showed intact recall. A second instance of hyperventilation evoked the appearance of pseudo-rhythmic slow activity localized to the right hemisphere, associated with left-sided weakness, 20 seconds after the end of the test. This event spontaneously resolved in 3 minutes and was followed by headache.An exaggerated physiologic response to hyperventilation, the possible epileptic nature of the events, and a migraine variant were all considered in the differential. Nonetheless, the EEG slowing is shorter in duration and generalized in physiologic and paraphysiological conditions. A clear ictal morphology and evolution of the EEG activity were lacking in this case, and migraine attacks induced by hyperpnea have not been reported to date. Instead, EEG alterations similar to that observed in our patient are described in association with vascular abnormalities. We report the clinical presentation and diagnostic workup of a rare cerebrovascular disorder, highlighting the key features in the differential. Our case emphasizes the clinical value of the EEG rebuild-up phenomenon, which can help the clinician in achieving a prompt diagnosis.


Asunto(s)
Electroencefalografía , Hemiplejía , Hiperventilación , Humanos , Femenino , Hiperventilación/fisiopatología , Hiperventilación/complicaciones , Niño , Hemiplejía/fisiopatología , Hemiplejía/diagnóstico , Hemiplejía/etiología , Cefalea/fisiopatología , Cefalea/etiología
5.
Adv Rheumatol ; 64(1): 58, 2024 Aug 12.
Artículo en Inglés | MEDLINE | ID: mdl-39135131

RESUMEN

BACKGROUND: Patients with immune-mediated rheumatic diseases (IMRDs) have been prioritized for COVID-19 vaccination to mitigate the infection severity risks. Patients with rheumatoid arthritis (RA) are at a high risk of severe COVID-19 outcomes, especially those under immunosuppression or with associated comorbidities. However, few studies have assessed the safety of the COVID-19 vaccine in patients with RA. OBJECTIVE: To evaluate the safety of vaccines against SARS-CoV-2 in patients with RA. METHODS: This data are from the study "Safety and Efficacy on COVID-19 Vaccine in Rheumatic Diseases," a Brazilian multicentric prospective phase IV study to evaluate COVID-19 vaccine in IMRDs in Brazil. Adverse events (AEs) in patients with RA of all centers were assessed after two doses of ChAdOx1 (Oxford/AstraZeneca) or CoronaVac (Sinovac/Butantan). Stratification of postvaccination AEs was performed using a diary, filled out daily and returned at the end of 28 days for each dose. RESULTS: A total of 188 patients with RA were include, 90% female. CoronaVac was used in 109 patients and ChAdOx1 in 79. Only mild AEs were observed, mainly after the first dose. The most common AEs after the first dose were pain at the injection (46,7%), headache (39,4%), arthralgia (39,4%), myalgia (30,5%) and fatigue (26,6%), and ChAdOx1 had a higher frequency of pain at the injection (66% vs 32 %, p < 0.001) arthralgia (62% vs 22%, p < 0.001) and myalgia (45% vs 20%, p < 0.001) compared to CoronaVac. The more common AEs after the second dose were pain at the injection (37%), arthralgia (31%), myalgia (23%), headache (21%) and fatigue (18%). Arthralgia (41,4% vs 25%, p = 0.02) and pain at injection (51,4% vs 27%, p = 0.001) were more common with ChAdOx1. No serious AEs were related. With Regard to RA activity level, no significant difference was observed between the three time periods for both COVID-19 vaccines. CONCLUSION: In the comparison between the two immunizers in patients with RA, local reactions and musculoskeletal symptoms were more frequent with ChAdOx1 than with CoronaVac, especially after the first dose. In summary, the AE occurred mainly after the first dose, and were mild, like previous data from others immunizing agents in patients with rheumatoid arthritis. Vaccination did not worsen the degree of disease activity.


Asunto(s)
Artritis Reumatoide , Vacunas contra la COVID-19 , COVID-19 , ChAdOx1 nCoV-19 , Humanos , Artritis Reumatoide/tratamiento farmacológico , Artritis Reumatoide/complicaciones , Femenino , Masculino , Brasil/epidemiología , Persona de Mediana Edad , COVID-19/prevención & control , COVID-19/complicaciones , Vacunas contra la COVID-19/efectos adversos , Vacunas contra la COVID-19/administración & dosificación , ChAdOx1 nCoV-19/efectos adversos , Estudios Prospectivos , Adulto , SARS-CoV-2/inmunología , Anciano , Cefalea/inducido químicamente , Cefalea/etiología , Mialgia/inducido químicamente , Mialgia/etiología , Artralgia/etiología , Vacunas de Productos Inactivados
6.
Eur J Neurol ; 31(9): e16385, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-39092827

RESUMEN

BACKGROUND: Acute headache may be the primary symptom of subarachnoid hemorrhage (SAH). Recent guidelines suggest that non-contrast computed tomography (CT) is adequate to exclude aneurysmal SAH if performed within 6 h after symptom onset. However, most studies of acute headache including CT, lumbar puncture and SAH are multicenter studies from referral hospitals with highly selected patient populations. The main purpose of this study was to describe the diagnostic properties of head CT and cerebrospinal fluid (CSF) spectrophotometry for detecting SAH in an unselected primary hospital population with acute headache. METHODS: A retrospective cross-sectional study conducted at a large primary hospital serving roughly 10% of the Norwegian population. Diagnostic workup from consecutive patients evaluated for acute headache in 2009-2020 were collected. All CSF-spectrophotometry reports were standardized and the same CT scanner was used during the study. RESULTS: A total of 3227 patients were included. Median age was 45 years and 63% were women. In total, 170 (5.3% of all acute headache patients) had SAH. Of 3071 CT-negative patients, 2852 (93%) underwent lumbar puncture. Of the CSF reports, 2796 (98%) were negative for xanthochromia. Overall, the rate for detection of aneurysmal SAH by positive xanthochromia was 9 in 2852 cases (3‰). The miss rate for the detection of an aneurysmal SAH with a CT scan within 6 h was 0 and within 12 h 1 in 2852 cases (0.3‰). CONCLUSION: In acute headache, a CT scan taken within 6 h is practically 100% sensitive for detecting any SAH.


Asunto(s)
Cefalea , Hemorragia Subaracnoidea , Tomografía Computarizada por Rayos X , Humanos , Hemorragia Subaracnoidea/complicaciones , Hemorragia Subaracnoidea/diagnóstico , Hemorragia Subaracnoidea/líquido cefalorraquídeo , Hemorragia Subaracnoidea/epidemiología , Femenino , Masculino , Noruega/epidemiología , Persona de Mediana Edad , Estudios Transversales , Adulto , Cefalea/diagnóstico , Cefalea/epidemiología , Cefalea/líquido cefalorraquídeo , Cefalea/etiología , Estudios Retrospectivos , Anciano , Punción Espinal , Anciano de 80 o más Años
8.
Cephalalgia ; 44(8): 3331024241268290, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-39099427

RESUMEN

BACKGROUND AND METHODS: In this narrative review, we introduce key artificial intelligence (AI) and machine learning (ML) concepts, aimed at headache clinicians and researchers. Thereafter, we thoroughly review the use of AI in headache, based on a comprehensive literature search across PubMed, Embase and IEEExplore. Finally, we discuss limitations, as well as ethical and political perspectives. RESULTS: We identified six main research topics. First, natural language processing can be used to effectively extract and systematize unstructured headache research data, such as from electronic health records. Second, the most common application of ML is for classification of headache disorders, typically based on clinical record data, or neuroimaging data, with accuracies ranging from around 60% to well over 90%. Third, ML is used for prediction of headache disease trajectories. Fourth, ML shows promise in forecasting of headaches using self-reported data such as triggers and premonitory symptoms, data from wearable sensors and external data. Fifth and sixth, ML can be used for prediction of treatment responses and inference of treatment effects, respectively, aiming to optimize and individualize headache management. CONCLUSIONS: The potential uses of AI and ML in headache are broad, but, at present, many studies suffer from poor reporting and lack out-of-sample evaluation, and most models are not validated in a clinical setting.


Asunto(s)
Inteligencia Artificial , Cefalea , Aprendizaje Automático , Humanos , Cefalea/diagnóstico , Cefalea/clasificación , Procesamiento de Lenguaje Natural
10.
Br J Hosp Med (Lond) ; 85(7): 1-4, 2024 Jul 30.
Artículo en Inglés | MEDLINE | ID: mdl-39078913

RESUMEN

This case report follows the events of a 36-year-old woman who presented to a hospital five days post-partum with an acute severe headache and vomiting. Despite a normal initial computed tomography (CT) head scan, a CT venogram was done due to neurological deterioration and revealed hydrocephalus secondary to subarachnoid haemorrhage (SAH). We discuss the role of CT imaging in the diagnosis of SAH, the risks of current guidelines for lumbar puncture (LP) and describe other important differential diagnoses for headache in the postpartum patient.


Asunto(s)
Cefalea , Hidrocefalia , Hemorragia Subaracnoidea , Tomografía Computarizada por Rayos X , Humanos , Femenino , Adulto , Cefalea/etiología , Hemorragia Subaracnoidea/complicaciones , Hemorragia Subaracnoidea/diagnóstico , Hidrocefalia/diagnóstico por imagen , Hidrocefalia/etiología , Diagnóstico Diferencial , Punción Espinal/métodos , Enfermedad Aguda , Vómitos/etiología
11.
Cent Eur J Public Health ; 32(2): 95-100, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-39069312

RESUMEN

OBJECTIVES: The current study examined the links and interactions among headaches, screen-based media use, physical activity, sleep, and the family environment in Lithuanian school-aged children during the second COVID-19 lockdown. METHODS: The study comprised data of 541 children aged 7-14 years from different Lithuania regions, and without chronic health conditions or developmental disorders. Information about the child was provided by their parents or caregivers who filled questionnaire on child's screen time, sleep duration and quality, physical activity, parental distress, parent-child relationship, history of child's headaches and infectious diseases. RESULTS: During the study period, 54% of the children had headaches, and the frequency was positively associated with child's age, screen time and parental distress, as well as negatively related to physical activity (PA), sleep quality, and the parent-child relationship. Parental education was related to child's PA, screen time and sleep quality. The results of binary logistic regression analysis and path analysis revealed that sleep quality and parental distress were significant predictors of headaches in children. CONCLUSIONS: Family and child or adolescent education and lifestyle modification aiming to improve sleep hygiene and PA, and to reduce screen-based sedentary behaviour should be provided. Family centred approach for more effective coping with distress and improvement of parent-child relationship is also important in treating child and adolescent headache.


Asunto(s)
COVID-19 , Ejercicio Físico , Cefalea , Tiempo de Pantalla , Humanos , COVID-19/epidemiología , Niño , Adolescente , Masculino , Femenino , Cefalea/epidemiología , Lituania/epidemiología , Relaciones Padres-Hijo , SARS-CoV-2 , Encuestas y Cuestionarios , Pandemias , Cuarentena/psicología
12.
Artículo en Ruso | MEDLINE | ID: mdl-39072569

RESUMEN

OBJECTIVE: To study the features of the primary forms of headache in patients with a confirmed diagnosis of multiple sclerosis (MS). MATERIAL AND METHODS: A total of 110 patients with MS were examined in the outpatient appointment of a neurologist at the Department of Neurology and Neurosurgery of the «Smolensk State Medical University¼ in the period from April 1, 2023 to May 31, 2023. A group of 20 people with a diagnosis of primary headache (PH) was selected. At the same time, a control group of 20 people with a diagnosis of PH was selected on the basis of the Center for Industrial Medicine of the Federal State Medical Institution MSU No. 135, Desnogorsk. The analysis of complaints, anamnestic, laboratory data, neurological status and test results on specialized scales was carried out. RESULTS: Migraine was the most frequent type of headache in MS patients (in a ratio of 5.6:1 compared to tension headache) and was observed in 17 (85%) MS patients. Tension headache was diagnosed only in 3 (15%) patients (p=0.002). Headache was significantly more common in the remitting form of MS (p=0.046). Age, total cholesterol level, EDSS level, type of MS disease-modifying therapy were not associated with the risk of developing headache. When comparing the population of patients with MS and PH with the control group on the anxiety and depression scale and the MoCA test, statistically significant differences were obtained (p<0.05). CONCLUSION: PH were diagnosed in 18.2% of patients with MS, with a much higher prevalence of migraines than tension headache. In addition, female gender and the type of MS are significantly associated with the risk of migraine. Migraine, as a comorbid condition, can aggravate cognitive impairment in patients with MS, characterized by a lower value of the MoCA scale, especially together with the progression of anxiety and depressive disorders. These findings indicate the need for a larger epidemiological study to accurately assess the prevalence of PH in patients with MS in the Smolensk region.


Asunto(s)
Trastornos Migrañosos , Esclerosis Múltiple , Humanos , Femenino , Masculino , Adulto , Esclerosis Múltiple/complicaciones , Esclerosis Múltiple/epidemiología , Persona de Mediana Edad , Trastornos Migrañosos/epidemiología , Trastornos Migrañosos/complicaciones , Trastornos Migrañosos/diagnóstico , Cefalea de Tipo Tensional/epidemiología , Cefalea de Tipo Tensional/diagnóstico , Cefalea/epidemiología , Cefalea/etiología
13.
J Tradit Chin Med ; 44(4): 839-850, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-39066545

RESUMEN

OBJECTIVE: To summarize the evidence from Traditional Chinese Medicine (TCM) practice in the treatment of acute primary headache and provide clinical practice guidance. METHODS: The guidelines were developed in accordance with the World Health Organization guideline development manual. After the establishment of steering committee, panel and the registration and protocol formulation, the evidence on TCM for acute primary headache from published guidelines, clinical evidence, and expert experience and consensus were collected. The grading of recommendations assessment, development and evaluation method was used to grade the evidence and make the recommendations. RESULTS: Based on the available evidence, the guidelines recommended three TCM herbal decoctions, six Chinese patent medicines, and two kinds of external application of Chinese herbal medicines. Diagnostic recommendations based on the expert experience and consensus were also included in the guidelines. CONCLUSION: TCM diagnosis and treatment of decoction, Chinese patent medicine and external application for treating acute primary headache were recommended. We hope these guidelines will be helpful in standardize the TCM acute treatment of primary headache.


Asunto(s)
Medicamentos Herbarios Chinos , Cefalea , Medicina Tradicional China , Humanos , Medicamentos Herbarios Chinos/uso terapéutico , Medicina Tradicional China/normas , Medicina Tradicional China/métodos , Cefalea/tratamiento farmacológico , Guías de Práctica Clínica como Asunto , Enfermedad Aguda
14.
Medicine (Baltimore) ; 103(30): e39090, 2024 Jul 26.
Artículo en Inglés | MEDLINE | ID: mdl-39058873

RESUMEN

RATIONALE: Spontaneous intracranial hypotension (SIH) is a well-established condition typically presenting with disabling orthostatic headache. Corpus callosum agenesis (CCA) is one of the most common human brain malformations with a wide spectrum of associated malformations, chromosomal abnormalities, and clinical syndromes. PATIENT CONCERNS: A 53-year-old woman presented with recurrent orthostatic headache for about 1 month. The head computed tomography examination of the patient showed CCA and the initial pressure of subsequent lumbar puncture was only 5 centimeters cerebrospinal fluid. Magnetic resonance imaging examination confirmed CCA with gray matter heterotopia. DIAGNOSIS: The final diagnose was SIH related headache with CCA. INTERVENTION: The patient's symptom improved after oral hydration, intravenous fluids, and bed rest. OUTCOME: Favorable outcome was observed. LESSONS: Although this co-occurrence of SIH and CCA is probably coincidental, this finding suggests that the developmental malformations of the brain may lead to structural changes in brain tissue or disturbances in cerebrospinal fluid production and reflux, resulting in pathological changes over time.


Asunto(s)
Agenesia del Cuerpo Calloso , Hipotensión Intracraneal , Humanos , Femenino , Hipotensión Intracraneal/diagnóstico , Hipotensión Intracraneal/complicaciones , Hipotensión Intracraneal/terapia , Persona de Mediana Edad , Agenesia del Cuerpo Calloso/complicaciones , Agenesia del Cuerpo Calloso/diagnóstico , Cefalea/etiología , Imagen por Resonancia Magnética , Tomografía Computarizada por Rayos X
15.
Artículo en Inglés | MEDLINE | ID: mdl-39063391

RESUMEN

BACKGROUND: Headache is among the most common symptoms following concussion, yet headache after concussion (HAC) remains poorly characterized. This study describes headache characteristics over the first four weeks following pediatric sport-related concussion. METHODS: This is a retrospective case series of 87 athletes (mean: 14.9 years; range: 8.4-18.8 years; 38% female) treated in a specialty sports concussion clinic within 28 days of injury. Primary outcomes of headache consistency, frequency, duration, and associated migrainous symptoms were assessed at immediate (0 to 48 h) and weekly time points over the first 28 days post-injury. Generalized mixed linear models compared headache characteristics across time points. Secondary analyses compared each outcome by as-needed analgesic use. RESULTS: During the immediate post-injury period, headache was more often constant (p = 0.002) and associated with migrainous symptoms (p < 0.001). By the third week post-injury, episodic headache was more prevalent (p < 0.001). Most patients (54%) transitioned from constant, migrainous headache to episodic, non-migrainous headache. This finding was uninfluenced by as-needed analgesic medication use. CONCLUSIONS: These findings document the trajectory of HAC. Future studies should assess relationships between initial headache characteristics and recovery.


Asunto(s)
Traumatismos en Atletas , Conmoción Encefálica , Cefalea , Humanos , Femenino , Masculino , Adolescente , Estudios Retrospectivos , Conmoción Encefálica/complicaciones , Niño , Traumatismos en Atletas/complicaciones , Traumatismos en Atletas/epidemiología , Cefalea/etiología
16.
Eur J Sport Sci ; 24(7): 964-974, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38956787

RESUMEN

The prolonged consequences of SARS-CoV-2 on young elite athletes recovering from primary and reinfection are unclear. This study aimed to assess inspiratory/expiratory muscle strength and respiratory function at the time of spontaneous recovery at 3, 6, and 9 months after SARS-CoV-2 primary and reinfection in elite athletes. The study enrolled 25 elite male judoists, including 11 primary infection cases, five reinfection cases, and nine controls from the Türkiye Olympic Preparation Center. Inspiratory/expiratory muscle strength and respiratory function were measured, including maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), FEV1/FVC, and peak expiratory flow (PEF) before and up to 9 months after SARS-CoV-2 infection in the early pre-competition preparation phases. The most common symptoms reported by reinfection cases were fatigue (80%), dyspnea (60%), and muscle/joint pain (60%), while primary infection cases reported fatigue (73%), muscle/joint pain (45%), and headache (45%). MIP decreased by -14% and MEP decreased by -13% following the SARS-CoV-2 infection in reinfection cases. Likewise, FEV1 and FVC decreased by -5% and -8%, respectively; consequently, FEV1/FVC increased by 3%. Inspiratory/expiratory muscle strength and respiratory function improved rapidly after 9 months of SARS-CoV-2 infection in primary cases, whereas dysfunction persisted in reinfection cases. PEF was unaffected throughout the 9-month follow-up period. Reinfection may lead to further alterations in respiratory system relative to the primary infection, with a suspected restrictive pattern that remains dysfunctional in the third month; however, it improves significantly during a 9-month follow-up period.


Asunto(s)
COVID-19 , Fuerza Muscular , Calidad de Vida , Humanos , Masculino , Estudios Prospectivos , Estudios de Seguimiento , Fuerza Muscular/fisiología , Adulto Joven , Músculos Respiratorios/fisiología , Músculos Respiratorios/fisiopatología , Atletas , Rendimiento Atlético/fisiología , Reinfección , SARS-CoV-2 , Pruebas de Función Respiratoria , Fatiga/fisiopatología , Disnea/fisiopatología , Adolescente , Capacidad Vital , Cefalea , Volumen Espiratorio Forzado
17.
BMC Musculoskelet Disord ; 25(1): 569, 2024 Jul 22.
Artículo en Inglés | MEDLINE | ID: mdl-39034398

RESUMEN

BACKGROUND: Chronic pain is a highly prevalent medical condition that negatively impacts quality of life and is associated with considerable functional disability. Certain diseases, such as fibromyalgia, headache, paraplegia, neuropathy, and multiple sclerosis, manifest with chronic pain. OBJECTIVE: The aim of this study is to examine the number and type of tweets (original or retweet) related to chronic pain, as well as to analyze the emotions and compare the societal impact of the diseases under study. METHODS: We investigated tweets posted between January 1, 2018, and December 31, 2022, by Twitter users in English and Spanish, as well as the generated retweets. Additionally, emotions were extracted from these tweets and their diffusion was analyzed. Furthermore, the topics most frequently discussed by users were collected. RESULTS: A total of 72,874 tweets were analyzed, including 44,467 in English and 28,407 in Spanish. Paraplegia represented 23.3% with 16,461 of the classified tweets, followed by headache and fibromyalgia with 15,337 (21.7%) and 15,179 (21.5%) tweets, respectively. Multiple sclerosis generated 14,781 tweets (21%), and the fewest tweets were related to neuropathy with 8,830 tweets (12.5%). The results showed that the primary emotions extracted were "fear" and "sadness." Additionally, the reach and impact of these tweets were investigated through the generated retweets, with those related to headaches showing the highest interest and interaction among users. CONCLUSION: Our results underscore the potential of leveraging social media for a better understanding of patients suffering from chronic pain and its impact on society. Among the most frequently encountered topics are those related to treatment, symptoms, or causes of the disease. Therefore, it is relevant to inform the patient to prevent misconceptions regarding their illness.


Asunto(s)
Dolor Crónico , Medios de Comunicación Sociales , Humanos , Medios de Comunicación Sociales/estadística & datos numéricos , Dolor Crónico/psicología , Dolor Crónico/epidemiología , Estudios Transversales , Emociones , Fibromialgia/psicología , Fibromialgia/epidemiología , Opinión Pública , Esclerosis Múltiple/psicología , Esclerosis Múltiple/epidemiología , Paraplejía/psicología , Paraplejía/epidemiología , Calidad de Vida/psicología , Cefalea/psicología , Cefalea/epidemiología
18.
Cephalalgia ; 44(7): 3331024241265881, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-39043228

RESUMEN

BACKGROUND: Sturge-Weber syndrome (SWS) is a neurocutaneous disorder for which the neurological aspects, particularly headaches, remain poorly understood, despite significantly affecting morbidity. The present study aimed to elucidate the prevalence, characteristics and treatment strategies, as well as explore the pathogenesis of headaches, in SWS. METHODS: Using Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, we systematically reviewed observational studies, case reports and series from eight databases (Cochrane Library, EBSCO, Embase, Medline, PubMed, Science Direct, Scopus and Web of Science), published from 1978 to 2023, to investigate the prevalence, characteristics, medication response and pathogenic theories of headaches in SWS. RESULTS: The review analyzed 48 studies, uncovering headache prevalence between 37% and 71%. Migraine-like headache affected up to 52% of individuals. Prophylactic and acute treatments included non-steroidal anti-inflammatory drugs, triptans and antiepileptic drugs, despite the lack of established guidelines. Life-threatening headaches in SWS are uncommon, typically accompanied by other neurological symptoms. The pathogenesis of headaches in SWS is considered to involve venous congestion and neuronal hyperexcitability linked to leptomeningeal angiomas. CONCLUSIONS: Headaches occur more frequently in individuals with SWS than in the general population. Despite symptoms meeting migraine criteria, these headaches should be considered secondary to vascular conditions. Implementing acute and prophylactic treatment is advised to reduce the impact on patients' lives.


Asunto(s)
Cefalea , Síndrome de Sturge-Weber , Síndrome de Sturge-Weber/complicaciones , Síndrome de Sturge-Weber/epidemiología , Humanos , Cefalea/epidemiología , Cefalea/etiología
19.
BMJ Case Rep ; 17(7)2024 Jul 23.
Artículo en Inglés | MEDLINE | ID: mdl-39043462

RESUMEN

Headache and neurological deficits with cerebrospinal fluid (CSF) lymphocytosis (HaNDL) is a rare condition characterised by recurrent episodes of headache and transient neurological deficits. This case report presents a young patient initially diagnosed with hemiplegic migraine, having a normal brain CT, with focal cerebral perfusion mismatch not restricted to a single vascular territory on CT angiography. Brain MRI revealed a cytotoxic lesion of the splenium in the corpus callosum (CLOCC), a feature also reported in migraine. However, recurrent headaches with neurological deficits prompted further investigations with CSF analysis and brain MRI, confirming HaNDL and demonstrating reversibility of CLOCC. Recognising HaNDL as a differential diagnosis is essential in patients with recurrent headaches with focal neurological deficits, given the differences in therapeutic approach. The relationship between migraine and HaNDL is not fully understood, but they may share a pathophysiological link. Awareness of this is crucial for accurate diagnosis.


Asunto(s)
Cuerpo Calloso , Cefalea , Linfocitosis , Imagen por Resonancia Magnética , Humanos , Linfocitosis/líquido cefalorraquídeo , Linfocitosis/diagnóstico , Linfocitosis/complicaciones , Cuerpo Calloso/diagnóstico por imagen , Cuerpo Calloso/patología , Cefalea/etiología , Diagnóstico Diferencial , Adulto , Masculino , Femenino , Síndrome
20.
Endocrinol Diabetes Metab ; 7(4): e496, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-39001600

RESUMEN

INTRODUCTION: Sellar masses are common intracranial neoplasms. Their clinical manifestations vary widely and include headache. We aimed to determine whether the prevalence and characteristics of headache in patients with sellar tumours differ from the general population and to investigate the effect of tumour resection on this complaint. METHODS: We performed a prospective, controlled study in a single tertiary centre and included 57 patients that underwent transsphenoidal resection for a sellar mass (53% females, mean age 53.5 ± 16.4) and 29 of their partners (controls; 45% females, mean age 54.8 ± 14.9). Outcome measures were prevalence, characteristics and impact of headache 1 month preoperatively and at neurosurgical follow-up 3 months postoperatively. RESULTS: Preoperatively, the prevalence of regular headache (≥1 time per month) was higher in patients than in controls (54% vs. 17%, p < 0.001), and patients scored higher on headache impact questionnaires (all p ≤ 0.01). At postoperative follow-up, headache prevalence decreased in both groups, but the decrease in regular headache frequency and impact was larger in patients than in controls, and no between-group differences remained. CONCLUSIONS: More than half of patients with sellar tumours suffer from at least once-monthly headaches, and both regular headache occurrence and impact are higher compared with controls. The more pronounced decrease in headache complaints in patients versus controls at postoperative follow-up suggests an additional effect of tumour resection next to the factor time.


Asunto(s)
Cefalea , Neoplasias Hipofisarias , Humanos , Femenino , Persona de Mediana Edad , Masculino , Cefalea/etiología , Adulto , Anciano , Estudios Prospectivos , Neoplasias Hipofisarias/cirugía , Estudios de Seguimiento , Prevalencia , Silla Turca , Periodo Posoperatorio , Periodo Preoperatorio
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA